IL6 and colitis: Colonic levels of myeloperoxidase, IL-6, and TNF-α decreased significantly in rats treated with the mixture, while a significant decrease in (Toll-like receptor) TLR-4 mucosal gene expression and a significant improvement in colitis were observed.